{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,8]],"date-time":"2026-10-08T20:01:34Z","timestamp":1791489694528,"version":"4.3.4"},"reference-count":31,"publisher":"The Endocrine Society","issue":"9","license":[{"start":{"date-parts":[[2024,3,5]],"date-time":"2024-03-05T00:00:00Z","timestamp":1709596800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["81974124"],"award-info":[{"award-number":["81974124"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Shandong Key R&D Program","award":["2017GSF18118"],"award-info":[{"award-number":["2017GSF18118"]}]},{"name":"National Key Research and Development Project","award":["2016YFC0901503"],"award-info":[{"award-number":["2016YFC0901503"]}]},{"DOI":"10.13039\/501100015507","name":"Shandong First Medical University","doi-asserted-by":"publisher","award":["2019RC015"],"award-info":[{"award-number":["2019RC015"]}],"id":[{"id":"10.13039\/501100015507","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100015507","name":"Shandong First Medical University","doi-asserted-by":"publisher","award":["81770785"],"award-info":[{"award-number":["81770785"]}],"id":[{"id":"10.13039\/501100015507","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2024,8,13]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>X-linked hypophosphatemia (XLHR) is the most common genetic form of hypophosphatemic rickets (HR), which is caused by phosphate regulating endopeptidase homolog X-linked (PHEX) gene mutation. At present, the genotype\u2013phenotype relationship of XLHR and the pathogenic role of PHEX are not fully understood.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>In this study, we summarized clinical features in a new cohort of 49 HR patients and detected 16 novel PHEX and 5 novel non-PHEX variants. Subsequently, we studied the pathogenesis of new variants by protein expression, glycosylation analysis, subcellular localization, and endopeptidase activity.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>The results showed that missense variants (Q189H and X750R) slightly reduced protein expression without obviously altering protein length and localization, whereas truncating variants significantly impaired the synthesis of PHEX and produced a shorter immature protein in cells. Interestingly, no evident correlation was observed between mutation types and clinical phenotypes. However, when we analyzed the relationship between PHEX activity and serum phosphorus level, we found that patients with low PHEX activity tended to have severe hypophosphatemia and high rickets severity score. Following this observation, we established 2 new knock-in XLHR mouse models with 2 novel Phex variants (c.T1349C and c.C426G, respectively) using CRISPR\/Cas9 technology. Both mouse models demonstrated clinical manifestations of XLHR seen in patients, and PhexC426G mice showed more severe phenotype than PhexT1349C mice, which further confirmed the rationality of genotype\u2013PHEX enzymatic activity correlation analysis.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion<\/jats:title>\n                    <jats:p>Therefore, our findings demonstrated that novel PHEX variants could disrupt protein function via affecting protein synthesis, post-translational modification, cellular trafficking, and catalytic activity. Our study facilitates a better understanding of XLHR pathogenic mechanism and PHEX activity-phenotype correlation, which is of crucial importance for future diagnosis and treatment of XLHR.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1210\/clinem\/dgae120","type":"journal-article","created":{"date-parts":[[2024,3,5]],"date-time":"2024-03-05T18:47:23Z","timestamp":1709664443000},"page":"2242-2255","source":"Crossref","is-referenced-by-count":7,"title":["Characterization of Novel\n                    <i>PHEX<\/i>\n                    Variants in X-linked Hypophosphatemic Rickets and Genotype-PHEX Activity Correlation"],"prefix":"10.1210","volume":"109","author":[{"given":"Huixiao","family":"Wu","sequence":"first","affiliation":[{"name":"Department of Endocrinology and Metabolism, Shandong Provincial Hospital Affiliated to Shandong First Medical University , Jinan 250021, Shandong , China"},{"name":"Department of Endocrinology and Metabolism, Shandong Provincial Hospital, Cheeloo College of Medicine, Shandong University , Jinan 250021, Shandong , China"},{"name":"Institute of Endocrinology, Shandong Academy of Clinical Medicine , Jinan 250021, Shandong , China"},{"name":"Shandong Clinical Medical Center of Endocrinology and Metabolism , Jinan 250021, Shandong , China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hui","family":"Ying","sequence":"additional","affiliation":[{"name":"Department of Endocrinology and Metabolism, Shandong Provincial Hospital Affiliated to Shandong First Medical University , Jinan 250021, Shandong , China"},{"name":"Department of Endocrinology and Metabolism, Shandong Provincial Hospital, Cheeloo College of Medicine, Shandong University , Jinan 250021, Shandong , China"},{"name":"Institute of Endocrinology, Shandong Academy of Clinical Medicine , Jinan 250021, Shandong , China"},{"name":"Shandong Clinical Medical Center of Endocrinology and Metabolism , Jinan 250021, Shandong , China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wanyi","family":"Zhao","sequence":"additional","affiliation":[{"name":"Department of Endocrinology and Metabolism, Shandong Provincial Hospital Affiliated to Shandong First Medical University , Jinan 250021, Shandong , China"},{"name":"Department of Endocrinology and Metabolism, Shandong Provincial Hospital, Cheeloo College of Medicine, Shandong University , Jinan 250021, Shandong , China"},{"name":"Institute of Endocrinology, Shandong Academy of Clinical Medicine , Jinan 250021, Shandong , China"},{"name":"Shandong Clinical Medical Center of Endocrinology and Metabolism , Jinan 250021, Shandong , China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yan","family":"Sun","sequence":"additional","affiliation":[{"name":"Department of Pediatric, Shandong Provincial Hospital Affiliated to Shandong First Medical University , Jinan 250021, Shandong , China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yanzhou","family":"Wang","sequence":"additional","affiliation":[{"name":"Department of Pediatric Orthopedics, Shandong Provincial Hospital Affiliated to Shandong First Medical University , Jinan 250021, Shandong , China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xinyu","family":"Chen","sequence":"additional","affiliation":[{"name":"Department of Endocrinology and Metabolism, Shandong Provincial Hospital Affiliated to Shandong First Medical University , Jinan 250021, Shandong , China"},{"name":"Department of Endocrinology and Metabolism, Shandong Provincial Hospital, Cheeloo College of Medicine, Shandong University , Jinan 250021, Shandong , China"},{"name":"Institute of Endocrinology, Shandong Academy of Clinical Medicine , Jinan 250021, Shandong , China"},{"name":"Shandong Clinical Medical Center of Endocrinology and Metabolism , Jinan 250021, Shandong , China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Guimei","family":"Li","sequence":"additional","affiliation":[{"name":"Department of Pediatric, Shandong Provincial Hospital Affiliated to Shandong First Medical University , Jinan 250021, Shandong , China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yangyang","family":"Yao","sequence":"additional","affiliation":[{"name":"Department of Pediatric Orthopedics, Shandong Provincial Hospital Affiliated to Shandong First Medical University , Jinan 250021, Shandong , China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shuo","family":"Xu","sequence":"additional","affiliation":[{"name":"Department of Medical Imaging, Shandong Provincial Hospital Affiliated to Shandong First Medical University , Jinan 250021, Shandong , China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tianyou","family":"Li","sequence":"additional","affiliation":[{"name":"Department of Pediatric Orthopedics, Shandong Provincial Hospital Affiliated to Shandong First Medical University , Jinan 250021, Shandong , China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Li","family":"Fang","sequence":"additional","affiliation":[{"name":"Department of Endocrinology and Metabolism, Shandong Provincial Hospital Affiliated to Shandong First Medical University , Jinan 250021, Shandong , China"},{"name":"Department of Endocrinology and Metabolism, Shandong Provincial Hospital, Cheeloo College of Medicine, Shandong University , Jinan 250021, Shandong , China"},{"name":"Institute of Endocrinology, Shandong Academy of Clinical Medicine , Jinan 250021, Shandong , China"},{"name":"Shandong Clinical Medical Center of Endocrinology and Metabolism , Jinan 250021, Shandong , China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaoqing","family":"Sun","sequence":"additional","affiliation":[{"name":"Institute of Endocrinology, Shandong Academy of Clinical Medicine , Jinan 250021, Shandong , China"},{"name":"Shandong Clinical Medical Center of Endocrinology and Metabolism , Jinan 250021, Shandong , China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ning","family":"Wang","sequence":"additional","affiliation":[{"name":"Institute of Endocrinology, Shandong Academy of Clinical Medicine , Jinan 250021, Shandong , China"},{"name":"Shandong Clinical Medical Center of Endocrinology and Metabolism , Jinan 250021, Shandong , China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jin","family":"Xu","sequence":"additional","affiliation":[{"name":"Department of Endocrinology and Metabolism, Shandong Provincial Hospital Affiliated to Shandong First Medical University , Jinan 250021, Shandong , China"},{"name":"Department of Endocrinology and Metabolism, Shandong Provincial Hospital, Cheeloo College of Medicine, Shandong University , Jinan 250021, Shandong , China"},{"name":"Institute of Endocrinology, Shandong Academy of Clinical Medicine , Jinan 250021, Shandong , China"},{"name":"Shandong Clinical Medical Center of Endocrinology and Metabolism , Jinan 250021, Shandong , China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qingbo","family":"Guan","sequence":"additional","affiliation":[{"name":"Department of Endocrinology and Metabolism, Shandong Provincial Hospital Affiliated to Shandong First Medical University , Jinan 250021, Shandong , China"},{"name":"Department of Endocrinology and Metabolism, Shandong Provincial Hospital, Cheeloo College of Medicine, Shandong University , Jinan 250021, Shandong , China"},{"name":"Institute of Endocrinology, Shandong Academy of Clinical Medicine , Jinan 250021, Shandong , China"},{"name":"Shandong Clinical Medical Center of Endocrinology and Metabolism , Jinan 250021, Shandong , China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Weibo","family":"Xia","sequence":"additional","affiliation":[{"name":"Department of Endocrinology, Key Laboratory of Endocrinology, Ministry of Health, Peking Union Medical College Hospital, Chinese Academy of Medical Sciences & Peking Union Medical College , Beijing 100730 , China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Li","family":"Wang","sequence":"additional","affiliation":[{"name":"Independent Researcher , Tucson, AZ 85705 , USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ling","family":"Gao","sequence":"additional","affiliation":[{"name":"Department of Endocrinology and Metabolism, Shandong Provincial Hospital Affiliated to Shandong First Medical University , Jinan 250021, Shandong , China"},{"name":"Department of Endocrinology and Metabolism, Shandong Provincial Hospital, Cheeloo College of Medicine, Shandong University , Jinan 250021, Shandong , China"},{"name":"Institute of Endocrinology, Shandong Academy of Clinical Medicine , Jinan 250021, Shandong , China"},{"name":"Shandong Clinical Medical Center of Endocrinology and Metabolism , Jinan 250021, Shandong , China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3267-9292","authenticated-orcid":false,"given":"Jiajun","family":"Zhao","sequence":"additional","affiliation":[{"name":"Department of Endocrinology and Metabolism, Shandong Provincial Hospital Affiliated to Shandong First Medical University , Jinan 250021, Shandong , China"},{"name":"Department of Endocrinology and Metabolism, Shandong Provincial Hospital, Cheeloo College of Medicine, Shandong University , Jinan 250021, Shandong , China"},{"name":"Institute of Endocrinology, Shandong Academy of Clinical Medicine , Jinan 250021, Shandong , China"},{"name":"Shandong Clinical Medical Center of Endocrinology and Metabolism , Jinan 250021, Shandong , China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6743-8881","authenticated-orcid":false,"given":"Chao","family":"Xu","sequence":"additional","affiliation":[{"name":"Department of Endocrinology and Metabolism, Shandong Provincial Hospital Affiliated to Shandong First Medical University , Jinan 250021, Shandong , China"},{"name":"Department of Endocrinology and Metabolism, Shandong Provincial Hospital, Cheeloo College of Medicine, Shandong University , Jinan 250021, Shandong , China"},{"name":"Institute of Endocrinology, Shandong Academy of Clinical Medicine , Jinan 250021, Shandong , China"},{"name":"Shandong Clinical Medical Center of Endocrinology and Metabolism , Jinan 250021, Shandong , China"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"80","published-online":{"date-parts":[[2024,3,5]]},"reference":[{"issue":"1","key":"2024081223513756700_dgae120-B1","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1016\/j.pcl.2018.09.004","article-title":"Hypophosphatemic rickets","volume":"66","author":"Bitzan","year":"2019","journal-title":"Pediatr Clin North Am"},{"issue":"6","key":"2024081223513756700_dgae120-B2","doi-asserted-by":"crossref","first-page":"460","DOI":"10.1097\/MED.0b013e328358be97","article-title":"Hypophosphatemic rickets","volume":"19","author":"Baroncelli","year":"2012","journal-title":"Curr Opin Endocrinol Diabetes Obes"},{"issue":"2","key":"2024081223513756700_dgae120-B3","doi-asserted-by":"crossref","first-page":"130","DOI":"10.1038\/ng1095-130","article-title":"A gene (PEX) with homologies to endopeptidases is mutated in patients with X-linked hypophosphatemic rickets. The HYP consortium","volume":"11","year":"1995","journal-title":"Nat Genet"},{"issue":"3","key":"2024081223513756700_dgae120-B4","doi-asserted-by":"crossref","first-page":"429","DOI":"10.1359\/JBMR.0301264","article-title":"FGF-23 is a potent regulator of vitamin D metabolism and phosphate homeostasis","volume":"19","author":"Shimada","year":"2004","journal-title":"J Bone Miner Res"},{"issue":"9","key":"2024081223513756700_dgae120-B5","doi-asserted-by":"crossref","first-page":"1718","DOI":"10.1002\/jbmr.4035","article-title":"Functional characterization of PHEX gene variants in children with X-linked hypophosphatemic rickets shows no evidence of genotype-phenotype correlation","volume":"35","author":"Zheng","year":"2020","journal-title":"J Bone Miner Res"},{"key":"2024081223513756700_dgae120-B6","doi-asserted-by":"crossref","first-page":"212","DOI":"10.1016\/j.bone.2019.01.021","article-title":"Clinical and genetic analysis in a large Chinese cohort of patients with X-linked hypophosphatemia","volume":"121","author":"Zhang","year":"2019","journal-title":"Bone"},{"issue":"2","key":"2024081223513756700_dgae120-B7","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1203\/01.PDR.0000169983.40758.7B","article-title":"A clinical and molecular genetic study of hypophosphatemic rickets in children","volume":"58","author":"Cho","year":"2005","journal-title":"Pediatr Res"},{"issue":"2","key":"2024081223513756700_dgae120-B8","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1530\/EJE-15-0515","article-title":"Hereditary hypophosphatemia in Norway: a retrospective population-based study of genotypes, phenotypes, and treatment complications","volume":"174","author":"Rafaelsen","year":"2016","journal-title":"Eur J Endocrinol"},{"issue":"8","key":"2024081223513756700_dgae120-B9","doi-asserted-by":"crossref","first-page":"3889","DOI":"10.1210\/jcem.86.8.7761","article-title":"Mutational analysis and genotype-phenotype correlation of the PHEX gene in X-linked hypophosphatemic rickets","volume":"86","author":"Holm","year":"2001","journal-title":"J Clin Endocrinol Metab"},{"issue":"1","key":"2024081223513756700_dgae120-B10","doi-asserted-by":"crossref","first-page":"116","DOI":"10.1186\/1471-2350-12-116","article-title":"Genetic diagnosis of X-linked dominant hypophosphatemic rickets in a cohort study: tubular reabsorption of phosphate and 1,25(OH)2D serum levels are associated with PHEX mutation type","volume":"12","author":"Morey","year":"2011","journal-title":"BMC Med Genet"},{"key":"2024081223513756700_dgae120-B11","doi-asserted-by":"crossref","first-page":"116135","DOI":"10.1016\/j.bone.2021.116135","article-title":"Genotype-phenotype analysis, and assessment of the importance of the zinc-binding site in PHEX in Japanese patients with X-linked hypophosphatemic rickets using 3D structure modeling","volume":"153","author":"Ishihara","year":"2021","journal-title":"Bone"},{"issue":"5","key":"2024081223513756700_dgae120-B12","doi-asserted-by":"crossref","first-page":"2213","DOI":"10.1210\/jc.2002-021809","article-title":"Structure and function of disease-causing missense mutations in the PHEX gene","volume":"88","author":"Sabbagh","year":"2003","journal-title":"J Clin Endocrinol Metab"},{"issue":"3","key":"2024081223513756700_dgae120-B13","doi-asserted-by":"crossref","first-page":"707","DOI":"10.1042\/bj3550707","article-title":"Characterization of PHEX endopeptidase catalytic activity: identification of parathyroid-hormone-related peptide107-139 as a substrate and osteocalcin, PPi and phosphate as inhibitors","volume":"355","author":"Boileau","year":"2001","journal-title":"Biochem J"},{"issue":"7","key":"2024081223513756700_dgae120-B14","doi-asserted-by":"crossref","first-page":"1468","DOI":"10.1002\/jbmr.141","article-title":"Guidelines for assessment of bone microstructure in rodents using micro-computed tomography","volume":"25","author":"Bouxsein","year":"2010","journal-title":"J Bone Miner Res"},{"issue":"7","key":"2024081223513756700_dgae120-B15","first-page":"487","article-title":"Height and weight standardized growth charts for Chinese children and adolescents aged 0 to 18 years","volume":"47","author":"Li","year":"2009","journal-title":"Zhonghua Er Ke Za Zhi"},{"key":"2024081223513756700_dgae120-B16","author":"Wu"},{"issue":"1","key":"2024081223513756700_dgae120-B17","doi-asserted-by":"crossref","first-page":"286","DOI":"10.1016\/j.bone.2012.10.012","article-title":"Novel and de novo PHEX mutations in patients with hypophosphatemic rickets","volume":"52","author":"Durmaz","year":"2013","journal-title":"Bone"},{"issue":"4","key":"2024081223513756700_dgae120-B18","doi-asserted-by":"crossref","first-page":"401","DOI":"10.1007\/s00439-009-0631-z","article-title":"PHEX analysis in 118 pedigrees reveals new genetic clues in hypophosphatemic rickets","volume":"125","author":"Gaucher","year":"2009","journal-title":"Hum Genet"},{"issue":"7","key":"2024081223513756700_dgae120-B19","doi-asserted-by":"crossref","first-page":"453","DOI":"10.1038\/jhg.2012.56","article-title":"Mutational analysis of PHEX, FGF23, DMP1, SLC34A3 and CLCN5 in patients with hypophosphatemic rickets","volume":"57","author":"Beck-Nielsen","year":"2012","journal-title":"J Hum Genet"},{"issue":"5","key":"2024081223513756700_dgae120-B20","doi-asserted-by":"crossref","first-page":"615","DOI":"10.1038\/sj.ejhg.5200341","article-title":"Non-random distribution of mutations in the PHEX gene, and under-detected missense mutations at non-conserved residues","volume":"7","author":"Filisetti","year":"1999","journal-title":"Eur J Hum Genet"},{"issue":"6","key":"2024081223513756700_dgae120-B21","doi-asserted-by":"crossref","first-page":"573","DOI":"10.1101\/gr.7.6.573","article-title":"Genomic organization of the human PEX gene mutated in X-linked dominant hypophosphatemic rickets","volume":"7","author":"Francis","year":"1997","journal-title":"Genome Res"},{"issue":"8","key":"2024081223513756700_dgae120-B22","doi-asserted-by":"crossref","first-page":"2244","DOI":"10.1681\/ASN.2018030228","article-title":"Detection of splicing abnormalities and genotype-phenotype correlation in X-linked alport syndrome","volume":"29","author":"Horinouchi","year":"2018","journal-title":"J Am Soc Nephrol"},{"issue":"4","key":"2024081223513756700_dgae120-B23","doi-asserted-by":"crossref","first-page":"695","DOI":"10.1359\/jbmr.090832","article-title":"Phosphorylation-dependent inhibition of mineralization by osteopontin ASARM peptides is regulated by PHEX cleavage","volume":"25","author":"Addison","year":"2010","journal-title":"J Bone Miner Res"},{"issue":"3","key":"2024081223513756700_dgae120-B24","doi-asserted-by":"crossref","first-page":"274","DOI":"10.1210\/er.2017-00220","article-title":"X-Linked hypophosphatemia and FGF23-related hypophosphatemic diseases: prospect for new treatment","volume":"39","author":"Kinoshita","year":"2018","journal-title":"Endocr Rev"},{"key":"2024081223513756700_dgae120-B25","doi-asserted-by":"crossref","first-page":"154049","DOI":"10.1016\/j.metabol.2019.154049","article-title":"Management of X-linked hypophosphatemia in adults","volume":"103S","author":"Lecoq","year":"2020","journal-title":"Metab Clin Exp"},{"issue":"7","key":"2024081223513756700_dgae120-B26","doi-asserted-by":"crossref","first-page":"435","DOI":"10.1038\/s41581-019-0152-5","article-title":"Clinical practice recommendations for the diagnosis and management of X-linked hypophosphataemia","volume":"15","author":"Haffner","year":"2019","journal-title":"Nat Rev Nephrol"},{"issue":"3","key":"2024081223513756700_dgae120-B27","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1007\/s00223-017-0363-3","article-title":"Impact of conventional medical therapy on bone mineral density and bone turnover in adult patients with X-linked hypophosphatemia: a 6-year prospective cohort study","volume":"102","author":"Shanbhogue","year":"2018","journal-title":"Calcif Tissue Int"},{"issue":"10189","key":"2024081223513756700_dgae120-B28","doi-asserted-by":"crossref","first-page":"2416","DOI":"10.1016\/S0140-6736(19)30654-3","article-title":"Burosumab versus conventional therapy in children with X-linked hypophosphataemia: a randomised, active-controlled, open-label, phase 3 trial [published correction appears in Lancet. 2019 Jul 13;394(10193):120]","volume":"393","author":"Imel","year":"2019","journal-title":"Lancet"},{"issue":"21","key":"2024081223513756700_dgae120-B29","doi-asserted-by":"crossref","first-page":"1987","DOI":"10.1056\/NEJMoa1714641","article-title":"Burosumab therapy in children with X-linked hypophosphatemia","volume":"378","author":"Carpenter","year":"2018","journal-title":"N Engl J Med"},{"issue":"8","key":"2024081223513756700_dgae120-B30","doi-asserted-by":"crossref","first-page":"1383","DOI":"10.1002\/jbmr.3475","article-title":"A randomized, double-blind, placebo-controlled, phase 3 trial evaluating the efficacy of burosumab, an anti-FGF23 antibody, in adults with X-linked hypophosphatemia: week 24 primary analysis","volume":"33","author":"Insogna","year":"2018","journal-title":"J Bone Miner Res"},{"issue":"1","key":"2024081223513756700_dgae120-B31","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1210\/clinem\/dgac488","article-title":"Approach to hypophosphatemic rickets","volume":"108","author":"Ackah","year":"2022","journal-title":"J Clin Endocrinol Metab"}],"container-title":["The Journal of Clinical Endocrinology &amp; Metabolism"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/academic.oup.com\/jcem\/advance-article-pdf\/doi\/10.1210\/clinem\/dgae120\/56962255\/dgae120.pdf","content-type":"application\/pdf","content-version":"am","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/jcem\/article-pdf\/109\/9\/2242\/58769465\/dgae120.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/jcem\/article-pdf\/109\/9\/2242\/58769465\/dgae120.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,8,12]],"date-time":"2024-08-12T21:08:24Z","timestamp":1723496904000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/jcem\/article\/109\/9\/2242\/7621860"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,3,5]]},"references-count":31,"journal-issue":{"issue":"9","published-online":{"date-parts":[[2024,3,5]]},"published-print":{"date-parts":[[2024,8,13]]}},"URL":"https:\/\/doi.org\/10.1210\/clinem\/dgae120","relation":{},"ISSN":["0021-972X","1945-7197"],"issn-type":[{"value":"0021-972X","type":"print"},{"value":"1945-7197","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2024,9]]},"published":{"date-parts":[[2024,3,5]]}}}